smart minimum ffr algorithm (Boston Scientific Corporation)
90
Structured Review
Boston Scientific Corporation
smart minimum ffr algorithm
Smart Minimum Ffr Algorithm, supplied by Boston Scientific Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/smart+minimum+ffr+algorithm/smart+minimum+ffr+algorithm/pm37477204-52-77-72
Average 90 stars, based on 1 article reviews
Smart Minimum Ffr Algorithm, supplied by Boston Scientific Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/smart+minimum+ffr+algorithm/smart+minimum+ffr+algorithm/pm37477204-52-77-72
Average 90 stars, based on 1 article reviews
smart minimum ffr algorithm - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Diagnostic Assay:Article Title: Coronary Atherosclerosis Phenotypes in Focal and Diffuse Disease. Article Snippet: Dr Johnson has received internal funding from the Weatherhead PET Center for Preventing and Reversing Atherosclerosis; significant institutional research support from St. Jude Medical (CONTRAST [Can Contrast Injection Better Approximate FFR Compared to Pure Resting Physiology? .. ]; NCT02184117) and Philips/Volcano Corporation (DEFINE-FLOW [Combined Pressure and Flow Measurements to Guide Treatment of Coronary Stenoses]; NCT02328820) for studies using intracoronary pressure and flow sensors; has an institutional licensing agreement with Boston Scientific for the smart-minimum Article Title: Left main PCI: beware the circumflex! Article Snippet: The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.. * Corresponding author.. Tel: +1 713 500 6611, Fax: +1 713 500 6615, Email: Nils.Johnson@uth.tmc.edu © The Author(s) 2023. Article Title: Is FFR dead? A conversation in cardiology. Article Snippet: After more than 20 years of studies showing the benefit of fractional flow reserve (FFR) for lesion assessment and directing decisions for percutaneous coronary intervention (PCI) or medical therapy in stable ischemic heart disease, the last few years have produced several negative studies on physiologically directed interventions.. Recently the FLAVOR study found no clinical outcome difference between FFR‐guided PCI compared to IVUS guided PCI.. Before accepting the results of any study, particularly those that might be practice changing, interventionalists should delve into the results more closely to see why these are contrarians in the face of many positive studies. Article Title: What About All the Recent "Negative" FFR Trials? Article Snippet: Study design for diagnostic strategies must focus on discordant decisions.. Composite endpoints for percutaneous coronary intervention (PCI) should discard mortality and focus on vessel-level outcomes for spontaneous myocardial infarction.. Initial PCI must be included when calculating the total amount of target vessel revascularization. Article Title: Biomechanical Evaluation of Aortic Valve Stenosis by Means of a Virtual Stress Test: A Fluid-Structure Interaction Study. Article Snippet: The impact of aortic valve stenosis (AS) extends beyond the vicinity of the narrowed leaflets into the left ventricle (LV) and into the systemic vasculature because of highly unpredictable valve behavior and complex blood flow in the ascending aorta that can be attributed to the strong interaction between the narrowed cusps and the ejected blood.. These effects can become exacerbated during exercise and may have implications for disease progression, accurate diagnosis, and timing of intervention.. In this 3-D patient-specific study, we employ strongly coupled fluid–structure interaction (FSI) modeling to perform a comprehensive biomechanical evaluation of systolic ejection dynamics in a stenosed aortic valve (AV) during increasing LV contraction. Article Title: Clinical and Vessel Characteristics Associated With Hard Outcomes After PCI and Their Combined Prognostic Implications Article Snippet: Dr Johnson has received institutional research support from Volcano/Philips (DEFINE‐FLOW [Combined Pressure and Flow Measurements to Guide Treatment of Coronary Stenoses], clinicaltrials.gov NCT02328820), Abiomed (for study of Impella‐related coronary physiology), and St. Jude Medical (CONTRAST [Can Contrast Injection Better Approximate FFR Compared to Pure Resting Physiology? .. ], clinicaltrials.gov NCT02184117); has an institutional licensing agreement with Boston Scientific for the Article Title: Clinical and Vessel Characteristics Associated With Hard Outcomes After PCI and Their Combined Prognostic Implications Article Snippet: Dr Johnson has received institutional research support from Volcano/Philips (DEFINE- FLOW [Combined Pressure and Flow Measurements to Guide Treatment of Coronary Stenoses], clini caltr ials.gov NCT02328820), Abiomed (for study of Impella- related coronary physiology), and St. Jude Medical (CONTRAST [Can Contrast Injection Better Approximate FFR Compared to Pure Resting Physiology? .. ], clini caltr ials.gov NCT02184117); has an institutional licensing agreement with Boston Scientific for the smart- minimum Positron Emission Tomography:Article Title: Left main PCI: beware the circumflex! Article Snippet: The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.. * Corresponding author.. Tel: +1 713 500 6611, Fax: +1 713 500 6615, Email: Nils.Johnson@uth.tmc.edu © The Author(s) 2023. other:Article Title: Influence of Pathophysiologic Patterns of Coronary Artery Disease on Immediate Percutaneous Coronary Intervention Outcomes Article Snippet: ; URL: https://www.clinicaltrials.gov; |